12 results
Atopic Dermatitis - Topical Treatment Options 
First Line: Topical Corticosteroids 
  - High Potency: Betamethasone
- Topical Treatment ... therapy is non-pharmacologic ... If all topical products ... Dermatitis #Topical #Treatment ... #Dermatology #Management
Atopic Dermatitis - Topical Treatment Options 
First Line: Topical Corticosteroids 
  - High Potency: Betamethasone
Atopic Dermatitis ... After non-pharmacologic ... Remember that all ... #Medications #Pharmacology ... #Dermatology #Management
A quick infographic on various pearls about atopic dermatitis, a disease with an increasing burden on
recommendations, treatments ... #medications #treatment ... #eczema #dermatology ... corticosteroids in dermatology ... versus conventional treatment
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Incidence: common in APL ... Triggers: ATRA treatment ... Imaging: CXR- pulmonary ... Renal Failure Treatment ... diagnosis #management #hematology
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
thiazidic, PPI, ACE ... constitutional symptoms • Treatment ... bDMARDs (rare), Topics ... life-threatening • Treatment ... comparison #table #rheumatology
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
Inhibitors of Na+K+2Cl ... Torsemide) • Acute pulmonary ... Tolvaptan) • Treatment ... Diuresis #Nephrology #Pharmacology
Causes of Lactate Elevation, Lactic Acidosis - Differential Diagnosis

The most common causes of hyperlactatemia are usually:
hypoperfusion - toxic-induced ... perfusion - shock->treatments ... before beginning treatment ... output - Acute pulmonary ... lactate and can act
A quick infographic on the importance of sun protection and the various results of sun damage
causes #diagnosis #dermatology ... Toxic effects of ... Kuriger JK, et al ... Kang S, Chien AL ... Mechanisms and treatments
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Disease: • 10%-15% Pulmonary ... , INC risk PE, Pulmonary ... Nephrogenic DI Hematologic ... Adenocarcinoma Treatment ... lubricants • Pharmacologic
Hemophagocytic Lymphohistiocytosis (HLH) Treatment
Primary HLH:
 - HLH-94 Protocol
    • Dexamethasone
Lymphohistiocytosis (HLH) Treatment ... trigger • Almost all ... autoimmune disease, treatment ... spare patient more toxic ... #management #hematology